Folic acid antagonists. 1952

H G PETERING

UI MeSH Term Description Entries
D005493 Folic Acid Antagonists Inhibitors of the enzyme, dihydrofolate reductase (TETRAHYDROFOLATE DEHYDROGENASE), which converts dihydrofolate (FH2) to tetrahydrofolate (FH4). They are frequently used in cancer chemotherapy. (From AMA, Drug Evaluations Annual, 1994, p2033) Antifolate,Antifolates,Dihydrofolate Reductase Inhibitor,Folic Acid Antagonist,Dihydrofolate Reductase Inhibitors,Folic Acid Metabolism Inhibitors,Acid Antagonist, Folic,Acid Antagonists, Folic,Antagonist, Folic Acid,Antagonists, Folic Acid,Inhibitor, Dihydrofolate Reductase,Inhibitors, Dihydrofolate Reductase,Reductase Inhibitor, Dihydrofolate,Reductase Inhibitors, Dihydrofolate
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

H G PETERING
January 1955, The American journal of clinical nutrition,
H G PETERING
August 1951, Orvosi hetilap,
H G PETERING
July 2004, Medizinische Monatsschrift fur Pharmazeuten,
H G PETERING
December 1951, Canadian Medical Association journal,
H G PETERING
February 1956, Revista medica de Cordoba,
H G PETERING
May 1966, British medical journal,
H G PETERING
February 1967, The British journal of dermatology,
H G PETERING
January 1949, Athena; rassegna mensile di biologia, clinica e terapia,
H G PETERING
January 1950, Le Sang,
H G PETERING
December 1964, Archives of dermatology,
Copied contents to your clipboard!